480 related articles for article (PubMed ID: 32997964)
1. Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy.
Wang W; Zou W
Mol Cell; 2020 Nov; 80(3):384-395. PubMed ID: 32997964
[TBL] [Abstract][Full Text] [Related]
2. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
3. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Nachef M; Ali AK; Almutairi SM; Lee SH
Front Immunol; 2021; 12():624324. PubMed ID: 33953707
[TBL] [Abstract][Full Text] [Related]
4. Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.
Anagnostakis F; Kokkorakis M; Markouli M; Piperi C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298344
[TBL] [Abstract][Full Text] [Related]
5. Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity.
Zheng Y; Yao Y; Ge T; Ge S; Jia R; Song X; Zhuang A
J Exp Clin Cancer Res; 2023 Nov; 42(1):291. PubMed ID: 37924140
[TBL] [Abstract][Full Text] [Related]
6. Solute Carriers in the Blood-Brain Barier: Safety in Abundance.
Nałęcz KA
Neurochem Res; 2017 Mar; 42(3):795-809. PubMed ID: 27503090
[TBL] [Abstract][Full Text] [Related]
7. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy.
Yang L; Chu Z; Liu M; Zou Q; Li J; Liu Q; Wang Y; Wang T; Xiang J; Wang B
J Hematol Oncol; 2023 Jun; 16(1):59. PubMed ID: 37277776
[TBL] [Abstract][Full Text] [Related]
8. ρ⁰ Cells Feature De-Ubiquitination of SLC Transporters and Increased Levels and Fluxes of Amino Acids.
Medina AB; Banaszczak M; Ni Y; Aretz I; Meierhofer D
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28425971
[TBL] [Abstract][Full Text] [Related]
9. Role of solute carrier transporters in regulating dendritic cell maturation and function.
Shao L; Yang M; Sun T; Xia H; Du D; Li X; Jie Z
Eur J Immunol; 2024 Feb; 54(2):e2350385. PubMed ID: 38073515
[TBL] [Abstract][Full Text] [Related]
10. Solute carrier transporters: emerging central players in tumour immunotherapy.
Chen R; Chen L
Trends Cell Biol; 2022 Mar; 32(3):186-201. PubMed ID: 34511324
[TBL] [Abstract][Full Text] [Related]
11. Harnessing Solute Carrier Transporters for Precision Oncology.
Nyquist MD; Prasad B; Mostaghel EA
Molecules; 2017 Mar; 22(4):. PubMed ID: 28350329
[TBL] [Abstract][Full Text] [Related]
12. Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.
Cha YJ; Kim ES; Koo JS
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562706
[TBL] [Abstract][Full Text] [Related]
13. Influenced tumor microenvironment and tumor immunity by amino acids.
Yu M; Zhang S
Front Immunol; 2023; 14():1118448. PubMed ID: 36798123
[TBL] [Abstract][Full Text] [Related]
14. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
[TBL] [Abstract][Full Text] [Related]
15. Tissue Site and the Cancer Immunity Cycle.
Horton BL; Fessenden TB; Spranger S
Trends Cancer; 2019 Oct; 5(10):593-603. PubMed ID: 31706507
[TBL] [Abstract][Full Text] [Related]
16. Amino Acid Metabolism in Lupus.
Kono M; Yoshida N; Tsokos GC
Front Immunol; 2021; 12():623844. PubMed ID: 33692797
[TBL] [Abstract][Full Text] [Related]
17. Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
Rangel Rivera GO; Knochelmann HM; Dwyer CJ; Smith AS; Wyatt MM; Rivera-Reyes AM; Thaxton JE; Paulos CM
Front Immunol; 2021; 12():645242. PubMed ID: 33815400
[TBL] [Abstract][Full Text] [Related]
18. Membrane transporters in cell physiology, cancer metabolism and drug response.
Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
[TBL] [Abstract][Full Text] [Related]
19. Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.
Anderson KG; Stromnes IM; Greenberg PD
Cancer Cell; 2017 Mar; 31(3):311-325. PubMed ID: 28292435
[TBL] [Abstract][Full Text] [Related]
20. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.
Zhao Y; Shao Q; Peng G
Cell Mol Immunol; 2020 Jan; 17(1):27-35. PubMed ID: 31853000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
